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ABSTRACT Haemophilus parasuis is a diverse bacterial species that is found in the
upper respiratory tracts of pigs and can also cause Glässer’s disease and pneumonia.
A previous pangenome study of H. parasuis identiﬁed 48 genes that were associated
with clinical disease. Here, we describe the development of a generalized linear
model (termed a pathotyping model) to predict the potential virulence of isolates of
H. parasuis based on a subset of 10 genes from the pangenome. A multiplex PCR
(mPCR) was constructed based on these genes, the results of which were entered
into the pathotyping model to yield a prediction of virulence. This new diagnostic
mPCR was tested on 143 ﬁeld isolates of H. parasuis that had previously been
whole-genome sequenced and a further 84 isolates from the United Kingdom from
cases of H. parasuis-related disease in pigs collected between 2013 and 2014. The
combination of the mPCR and the pathotyping model predicted the virulence of an
isolate with 78% accuracy for the original isolate collection and 90% for the addi-
tional isolate collection, providing an overall accuracy of 83% (81% sensitivity and
93% speciﬁcity) compared with that of the “current standard” of detailed clinical
metadata. This new pathotyping assay has the potential to aid surveillance and dis-
ease control in addition to serotyping data.
KEYWORDS Haemophilus parasuis, virulence factors, pathotyping, molecular
diagnostics
Haemophilus parasuis is a diverse Gram-negative bacterial species commonly foundas a commensal in the upper respiratory tract (URT) of the pig. Some isolates of this
bacterium can cause pneumonia as well as a systemic disease of pigs commonly known
as Glässer’s disease, with more severe presentations including arthritis, meningitis,
polyserositis, and septicemia (1–5). The U.K. Animal and Plant Health Agency (APHA)
reported an increase in H. parasuis-related outbreaks over the last few years (6), with 15
outbreaks involving Glässer’s disease and seven from pneumonia due to H. parasuis in
2015. H. parasuis can cause disease throughout the life cycle of the pig, affecting
nursery herds (commonly alongside porcine reproductive and respiratory syndrome
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virus [7]) as well as contributing to multifactorial porcine respiratory disease complex
(PRDC) in grower-ﬁnisher pigs (8).
Species-level identiﬁcation of H. parasuis can be useful diagnostically but is not
sufﬁcient for all situations. For example, the presence of H. parasuis in a swab from the
nose or from oral ﬂuid is not very informative, as this bacterium is a common member
of the ﬂora of the URT. Therefore, additional information of this bacterium would be
very useful to allow for more thorough surveillance. Several subtyping methods or
epidemiological tools are available, with serotyping (9–11) being the most commonly
used for this bacterium. However, serovar is regarded as a poor proxy for virulence, with
the exception of serovars 4 and 5 (12–14). The vtaAmultiplex PCR (mPCR) (15–17) is the
only method that has shown an association between the test result for a given isolate
and its virulence, but its wide-scale use has not been reported.
The link between virulence and serovar for H. parasuis is predominantly based on
early experimental reproduction of disease in speciﬁc-pathogen free (SPF) pigs using
the reference strains (with somewhat inconsistent results) and the globally prevalent
disease-causing isolates (1, 9, 13, 18). Serovars 4 and 5 are currently the most prevalent
disease-causing serovars of H. parasuis globally (12–14). However, generalization of the
virulence of a serovar is often made for all isolates based on SPF challenge studies
performed with small numbers of isolates and animals (1, 9, 18–21). Even the serovar
3 reference strain, widely considered to be avirulent, resulted in some clinical signs in
a recent challenge study using colostrum-deprived piglets (22). Therefore, a better
marker for virulence or understanding of virulence potential is required for this bacte-
rium.
Our previous analysis of more than 200 isolates of H. parasuis (23) revealed a diverse
pangenome of over 7,000 genes, with 1,049 genes classiﬁed as part of the core genome
(i.e., present in every isolate). However, no links between previously suggested viru-
lence factors and clinical metadata were found, i.e., no previously suggested virulence
factors were present in a high proportion of isolates from one category while absent
from the other and, consequently, were not useful as indicators of the virulence of an
isolate from the pangenome. Therefore, we used a genome-wide association study
(GWAS) approach (23) using discriminant analysis of principal components (24), which
identiﬁed 48 genes associated with disease, which could be found in either disease-
associated or carriage isolates. While the relative importance in virulence and the
functional roles of these newly designated virulence-associated genes have yet to be
investigated, they have the potential to aid in the prediction of the virulence of an
isolate based purely on their correlation with the virulent phenotype.
The deﬁnition of virulence for our studies has been carefully considered. The isolates
used in our previous pangenome analysis (23) were predominantly ﬁeld isolates with
detailed clinical metadata based on postmortem results (e.g., tissue of origin, serovar,
age of pig, antemortem signs, postmortem diagnosis, known welfare issues, and known
coinfections). This information was used to classify isolates of H. parasuis obtained from
systemic or respiratory sites as disease-associated isolates and all isolates from the URT
of healthy pigs as nondisease-associated or “carriage” isolates. In reality, these clinical
metadata are not a guaranteed means for determining disease-causing potential, as
many other factors may be involved in the outcome of an infection (additional host
factors and variation in the microbiota), and so we call the clinical metadata a silver
standard data set for comparison.
This paper describes the design and validation of an mPCR, termed a “pathotyping”
tool, which can be used to predict the virulence of an isolate based on a subset of 10
genes from the pangenome of H. parasuis.
RESULTS
Design of the pathotyping mPCR. The ﬁnal list of genes included in the model is
shown in Table 1 alongside their primers and information regarding their importance
in the model. This list included genes that were either positively or negatively associ-
ated with virulence and a species-speciﬁc marker that was designed based on one of
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the most conserved genes in the pangenome of H. parasuis (25). Two genes
(HPS_23879 and HPS_22976c) that were included in the model were found in high
proportions (85% and 78%, respectively) in the disease-associated Bayesian analysis of
population structure (BAPS) populations (BAPS 4 and BAPS 5) (23). The model mostly
included genes of unknown function but also included genes encoding an inosine-5-
monophosphate dehydrogenase, an aspartate kinase monofunctional class protein, a
helix-turn-helix family protein, and a glycosyltransferase. This pathotyping model had
an Akaike information criterion (estimate of the quality of the model) of 156.5, and the
area under the curve (AUC) was 0.88 (Fig. 1). The sensitivity and speciﬁcity of the model
were both estimated at greater than 80% using the receiver operating characteristic
(ROC) curve (Fig. 1) and led to the choice of a cutoff 0.72 for the model.
Validation of the pathotyping multiplex. The mPCR was validated using 143 of
the original H. parasuis isolates, with 115 being disease associated (80%) and 28 being
carriage isolates (20%). An example of a gel from the mPCR on 16 different isolates from
the additional isolate collection can be found in Fig. 2. A summary of the results of the
mPCR for these isolates can be seen in Table 2, and detailed information is provided in
Table S1 in the supplemental material. Overall, 88% of these isolates had the amplicon
pattern plus or minus one band compared with the expected pattern from the
presence or absence of each gene from the draft genome sequences of the isolates. For
those isolates where more than one amplicon difference was identiﬁed by the mPCR
(n  34), the model classiﬁed 85% as the same virulence category as the clinical
TABLE 1 Summary of isolates used in the validation of the mPCR based on serovar and country of origin
Country
No. of isolates
Disease-associated serovar Carriage serovar
1 2 4 5 or 12 6 7 9 13 14 15 Total 1 2 3 4 5 or 12 6 7 8 10 13 14 Total
Argentina 1 1
Denmark 1 1 6 5 2 3 1 6 1 1 27
Germany 2 2
Greece 1 1
Italy 1 1
Japan 1 1 2 2 1 5
Spain 1 5 1 1 1 9 1 1 1 2 2 7
Sweden 0
Switzerland 0 1 1
United Kingdom 2 7 23 11 2 9 2 8 1 3 68 1 2 3 1 2 3 12
Unknown 2 2 1 1 1 3
United States 1 1 1 3
Total 6 8 29 27 6 13 3 14 4 5 115 3 4 3 1 3 3 3 2 1 3 2 28
FIG 1 ROC curve for the ﬁnal model based on the 10 genes chosen for the pathotyping PCR. The curve
is labeled with the different cutoffs for the model to achieve the sensitivity and speciﬁcity at each point
on the curve. The lines represent the desired boundaries for 80% speciﬁcity and sensitivity to aid the
choice of model cutoff.
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metadata. Therefore, only 5 isolates varied by more than one band and had a different
virulence prediction from the clinical metadata. Taking the clinical metadata as the
“current or silver standard,” the sensitivity and speciﬁcity of the model and mPCR were
calculated at 75% and 93%, respectively, with an overall accuracy of 78%. For the
additional clinical isolate collection (Table 2), the amplicon patterns were entered into
the model, and 90% were predicted as being disease-associated isolates.
The amplicon patterns were identical whether genomic DNA (gDNA) or colony PCR
was used. Of the 11 genes in the mPCR, two were ampliﬁed from the negative-control
panel (Fig. 3), including HPS_21058 from one of the two isolates of Actinobacillus
porcinus (HS206) and HPS_23879 from the single isolate of Actinobacillus indolicus
(HS213), but no species-speciﬁc band was produced for any these isolates. Six reference
strains of H. parasuis were used to test the limit of detection of the mPCR. The average
minimum concentration of DNA detectable by the mPCR was determined to be 1.02
ng/l for an individual pure gDNA preparation or 3.4  105 genomes/l across the
isolates (Fig. 4).
DISCUSSION
We have described the development of a pathotyping mPCR assay exploiting the
recent discovery of putative virulence-associated genes based on a whole-genome
analysis of a large population of H. parasuis with well-characterized clinical origins. An
analysis of the pangenome of the original isolate collection showed that the majority
FIG 2 Results of the pathotyping multiplex on a subset of H. parasuis isolates from the additional isolate
collection. M, Quick-load 100 bp DNA ladder.
TABLE 2mPCR results for the original and additional isolate collections using the model
cutoff of 0.72a
PCR results
Metadata results (no. [type, %])
Disease associated Carriage Total
Original isolate collection
Disease associated 85 (TP, 75) 2 (FP, 7) 87
Carriage 30 (FN, 25) 26 (TN, 93) 56
Additional isolate collection
Disease associated 76 (TP, 90) 0 76
Carriage 8 (FN, 10) 0 8
Total 199 28 227
aThe table shows the categorization of the isolates according to available disease-associated metadata and
mPCR. The corresponding rates for true positives (TP), true negatives (TN), false positives (FP), and false
negatives (FN) are given.
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of previously published putative “virulence factors” for H. parasuis did not show a
strong relationship with virulence, as they were core genes (i.e., present in all isolates).
Furthermore, no single marker of virulence could be identiﬁed, emphasizing the
necessity for an mPCR approach for any future pathotyping tool. These ﬁndings meant
that the design of a diagnostic test to predict the virulence of isolates would not be
straightforward. Therefore, the decision was made to develop a pathotyping model for
H. parasuis based on a combination of genes found in higher proportions of disease-
associated isolates and in predominantly disease-associated BAPS populations together
with a set of virulence-associated genes from the GWAS analysis of the original isolate
collection (23). The resulting mPCR generated a pattern of 11 amplicons, including a
species-speciﬁc marker (25) which, when entered into the model, correctly predicted
the allocation of 78% of the original isolate collection to their observed virulence
category from our silver-standard clinical metadata. The majority of the genes targeted
by this mPCR have not previously been linked to virulence in H. parasuis or other
bacterial species, an exception being inosine-5=-monophosphate (IMP) dehydrogenase,
which has been implicated in the adhesion of Streptococcus suis serotype 2 (26). Testing
of the additional collection of disease-associated isolates resulted in a 90% accuracy.
Combining the results from both collections gave an overall accuracy of 83%.
There was no obvious pattern based on this mPCR for the prediction of virulence, as
each gene has its own importance in the model and may have a positive or negative
effect. In addition, the amplicon-based outcome was not cumulative, i.e., the number
of bands did not relate to the virulence potential, and so it is necessary to input the
amplicon pattern into the model to interpret the results of the mPCR and predict the
virulence potential. Therefore, we have developed a user-friendly online tool (https://
hps-pathotyping.shinyapps.io/Patho-app) to implement the model, built using R and
the Shiny package (v0.10.2.1; RStudio, Inc., Boston, MA), which requires only the input
of a table of the mPCR amplicon pattern. It then provides a ﬁtted value for the amplicon
FIG 3 Negative-control panel showing speciﬁcity of the primer sets across a range of commensal and
pathogenic bacteria of the pig respiratory tract (Haemophilus parasuis positive controls serovar 2 (SW140)
and serovar 5 (Nagasaki), Actinobacillus minor, A. porcinus, A. indolicus, Streptococcus suis, A. pleuropneu-
moniae, and Bordetella bronchiseptica). M, Quick-load 100 bp DNA ladder.
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pattern using the model and an associated interpretation of this value in simple
virulence categories: virulent, potentially virulent, and carriage. The additional category
of potentially virulent (based on a buffer zone of0.1 on the ﬁtted model value) allows
the user to interpret the risk of a particular isolate on a case-by-case basis. The
threshold for this buffer zone was chosen to minimize the false-positive and false-
negative rates for our model; but, in clinical practice, there are many additional factors
that contribute to the outcome of disease beyond bacterial genotype, such as the
interplay between host immunity and coinfections with additional pathogens present
at the time of challenge. For any approach that attempts only to determine the
genotype of the bacterial pathogen, it is unrealistic to be able to predict the outcome
of disease with 100% accuracy.
We identiﬁed a number of discrepancies between the expected and actual amplicon
patterns. These could be explained through errors in sequence assemblies, as we used
predominantly draft genome sequences. In addition, the assessment of the species
speciﬁcity of the mPCR revealed that two of the genes could be identiﬁed in single
representatives of commensal Actinobacillus species. This result was not predicted by
the BLAST comparison of the available draft genomes and may have occurred via
horizontal gene transfer in these closely related species.
The mPCR was developed from, and designed for use on, DNA extracted from
individual bacterial isolates. The presence of multiple isolates of H. parasuis, particularly
in URT samples (27–29), is one of the major challenges in designing a prospective
FIG 4 Limit of detection for the pathotyping multiplex PCR using pure genomic DNA (genomes/l) for
seven isolates representing all of the bands present in the pathotyping multiplex PCR. M, Quick-load 100
bp DNA ladder.
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molecular tool for determining virulence. Current surveillance methods for other
pathogens such as Actinobacillus pleuropneumoniae operate on an individual isolate
level, where the detection of the bacterium initiates a more thorough investigation at
the single-colony level to look for the presence of toxins (30, 31). We see this patho-
typing mPCR as a useful tool for surveillance as a preventative measure. For example,
if two herds were about to be mixed, then prospective surveillance sampling by nasal
swabs from these populations might enable the isolation of H. parasuis colonies (32),
which, in turn, could be tested by mPCR to determine whether different isolates are
being carried and if any are likely to cause disease when introduced to a naive
population. This could also be used in conjunction with a recently published mPCR for
molecular serotyping (25). Therefore, this mPCR approach to the pathotyping of H.
parasuis presents a major step forward for preventive health programs through its
rapidity as well as its speciﬁcity.
Ideally, any new research tool or diagnostic test should be compared against an
accepted “gold standard” assay. This enables meaningful comparisons of sensitivity,
speciﬁcity, and overall accuracy for the new test. For H. parasuis, this is challenging for
a number of reasons. First, the ideal standard would entail a panel of isolates for which
a series of consistently controlled in vivo challenge experiments had been performed
using pigs of identical immune status and genetics (1, 9, 13, 18). Both bacterial and host
factors impact signiﬁcantly the disease outcome for a given isolate, and although in
vivo challenge data are available for a number of isolates of H. parasuis, most of these
data come from separately published studies using small sets of isolates and under
differing conditions (1, 9, 13, 18). Our approach, which has its caveats, was to take a
large collection of ﬁeld-derived isolates from pigs with or without clinical evidence of
H. parasuis-related disease and to use this for comparative purposes as a silver standard.
These data were obtained from detailed postmortem results, including clinical signs,
the tissue of isolation, and the presence of any additional pathogens, and so a certain
number of false negatives and false positives were expected based on the unique
balance between host immunity and bacterial virulence potential in each individual
clinical context. However, we were able to perform an in silico comparison of our
isolates (23) to the existing vtaA mPCR primers (16) (data not shown) as the leading
method for the prediction of virulence to date. This was performed using BLAST, which
resulted in 82% sensitivity but only 56% speciﬁcity compared with our clinical meta-
data. Our mPCR had an accuracy (overall accuracy 83%) similar to that of the vtaAmPCR
(accuracy 80%) when tested on our isolate collection, but, although the sensitivity was
slightly lower, it had a far higher speciﬁcity and exceeds the usefulness of previous
methods, such as ﬁngerprinting methods that have limited repeatability between
laboratories or usefulness in ﬁeld situations (33–36).
While our mPCR performed very well, a number of false negatives were identiﬁed
when testing on the original isolate collection. Of these, 59% were linked to coinfec-
tions or respiratory disease, and since pneumonia in pigs is typically a multifactorial
disease (37), it is likely that these isolates were coinfections. Similarly, for the additional
isolate collection, 4 of 9 (43%) false negatives were isolated from the lungs or from
animals that had respiratory disease. A far lower proportion of isolates was recorded as
false positive from the original isolate collection, with only 2 recorded from a total of
143 tested. These isolates were predicted, using our model, as being capable of causing
disease, but were isolates from the URT of a pig with no clinical evidence of disease.
This phenomenon could be explained by a preexisting passive or active immunity
resulting in subclinical carriage, which has been described in the ﬁeld and in controlled
challenge studies using disease-associated isolates (1, 38, 39).
This method was designed using a U.K.-biased isolate collection (54% of the original
isolate collection) from diverse serovars and will require testing against isolates from a
wider range of locations. However, the method offers ﬂexibility and can be easily
updated as additional training sets are studied, whether by changing the model cutoff
or adding new virulence markers or population-based markers that would give further
indications of mixed isolates in a sample. Overall, the proposed mPCR is an accurate,
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sensitive, and speciﬁc method for predicting the virulence of H. parasuis, which could
be applied to a variety of samples and, with further optimization, could become part of
prospective surveillance procedures.
MATERIALS AND METHODS
Isolate collection and culture. The pangenome of H. parasuis was previously deﬁned (23) based on
a collection of 212 diverse ﬁeld isolates and reference strains. For the ease of description, we refer to the
previously sequenced H. parasuis population as the original isolate collection, containing both the ﬁeld
isolates and the reference strains. In this study, we used a subset of this sequenced isolate collection with
the most detailed clinical metadata (including the tissue of origin, clinical signs from the postmortem
investigation, and cause of death) for the development and testing of this mPCR (n 143). This was used
as the training set for the mPCR. A summary of the training set based on geographic location, serovar,
and virulence is included in Table 1.
An additional 84 disease-associated isolates of H. parasuis were subsequently collected by the APHA,
and this was termed the additional isolate collection. These isolates were used as an outside test set with
known virulence but no expected amplicon pattern. Culture and gDNA extraction were performed as
described previously (23) for evaluation using the mPCR.
Isolates of closely related commensal Pasteurellaceae, including Actinobacillus indolicus (n  1
[European Nucleotide Archive no. ERS132160]), Actinobacillus minor (n  3 [ERS132116, ERS132158, and
ERS132165]), and Actinobacillus porcinus (n 2 [ERS132148 and ERS132163]) were identiﬁed from routine
APHA diagnostic investigations and were also genome sequenced. These genome sequences were used
to test the speciﬁcity of primers designed against H. parasuis (using BLASTn) and as part of the
negative-control panel. In addition, ﬁeld isolates of the pathogens Actinobacillus pleuropneumoniae (n 
3), Bordetella bronchiseptica (n  1), and Streptococcus suis (n  3) were used in the negative-control
panel for the mPCR.
Pathotyping multiplex design. (i) Gene choice. A list of candidate “virulence-associated” genes was
constructed from three sources. The ﬁrst was 48 virulence-associated genes identiﬁed from a GWAS of
the accessory genome (23, 24), including genes that were either positively or negatively associated with
virulence. The second source was 10 previously suggested virulence factors that were identiﬁed in more
than 60% of disease-associated isolates and less than 40% of carriage isolates from the pangenome
analysis (23). BAPS (23, 40) of H. parasuis had identiﬁed ﬁve populations, two of which were predomi-
nantly of disease-associated isolates (BAPS 4 to 95% and BAPS 5 to 98%). Genes that were found in a
large proportion of isolates from these BAPS populations (75%) were used as the third list (n  251).
Only three genes were identiﬁed in both the BAPS and GWAS lists.
This list of 306 genes was reﬁned for suitability as markers for a pathotyping mPCR. A gene was ruled
out as a candidate if it was less than 100 bp in length, if the predicted function of the gene was a
transposase, phage gene, or integrase, if there were no conserved regions in the gene to which primers
could be designed, or if the gene was commonly found to have a pseudogene in the previously
published pangenome (cutoff, 20% of representatives of a given gene were pseudogenes). Finally, a
species-speciﬁc marker for H. parasuis was also included as previously described (25).
(ii) Model optimization and statistical analysis. A series of stepwise logistic generalized linear
models (in both directions using the MASS R library [25, 41]) was used to build a model using disease
association as the phenotype and small subsets of the candidate genes (20) as independent variables
based on the presence and absence of each gene from the pangenome. The candidates that were
signiﬁcant in the models (P value  0.1) were taken forward to the second round. As combinations of
genes could contribute to virulence, situations in which up to ﬁve genes at a time were interacting were
investigated in the series of models. For example, the addition of genes A to E with interactions to the
model provided an estimation of the importance of each gene individually, the importance of all
combinations of two genes, three genes, and four genes, and ﬁnally, the importance of the combination
of all ﬁve genes together and whether this improved the model. Finally, these two lists were combined
and the model was assessed using stepwise selection again to remove spurious interactions.
The output of the model was a ﬁtted value between 0 and 1. We assessed the performance of the
model using the ROCR R package (42) to predict virulence by varying the cutoff on the scale of the ﬁtted
values; below the cutoff was considered “carriage” and above was considered “virulent.” The accuracy,
sensitivity, and speciﬁcity at each threshold were then calculated by comparing the predictions to the
known clinical category for the original isolate collection. Accuracy was deﬁned as the sum of true
positives (TP) and true negatives (TN) divided by all isolates tested. Sensitivity was deﬁned as the TP rate:
TP divided by TP and false negatives (FN). Speciﬁcity was deﬁned as the TN rate: TN divided by TN and
false positives (FP). An ROC curve was built using the ROCR R library (42), which is a plot of the sensitivity
and speciﬁcity for each cutoff, and was used to identify a cutoff for the model that achieved greater than
80% sensitivity and 80% speciﬁcity. We also proposed that a buffer zone of 0.1 be added to the model
cutoff, which we considered to be a category for “potentially virulent” isolates for the interpretation of
the user.
(iii) Primer design. Primer3 was used to design primers between 21 and 30 bases in length with 40
to 60% GC content based on the New England BioLabs (NEB) master mix guidelines for mPCR design.
The primers for each gene were compared to the H. parasuis genomes using BLASTn (word size 7) to
identify those that matched the presence/absence pattern of the genes in the original isolate collection.
Alignments of genes and primers were performed using MEGA (43) and were visually inspected to ensure
the best choice of primers given the desired product sizes. Errors of up to 10% in the matches of the
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primers to the H. parasuis genomes were allowed from the BLASTn results, allowing for the draft nature
of the genome sequences. The primers were then compared (using BLASTn with a word size of 7) to the
NCBI nonredundant (nr) nucleotide database and the closely related Pasteurellaceae bacterial genomes
to check for nonspeciﬁc primer matches. In addition to the primers for the virulence-associated genes,
a previously published species-speciﬁc primer pair was added to the mPCR (25). Primers were ordered
in dehydrated desalted form from Sigma-Aldrich (Haverhill, Cambridge).
One-step mPCR. The PCR master mix was prepared using OneTaq Quick-load 2 master mix with
standard buffer (New England BioLabs) in accordance with product speciﬁcations and protocols. After
optimization, the ﬁnal protocol for ampliﬁcation of the targets was initiation at 94°C for 30 s, followed
by 30 cycles of denaturation at 94°C for 30 s, annealing at 54°C for 30 s, and extension at 68°C for 60 s,
followed by a ﬁnal extension at 68°C for 5 min. Each PCR mixture contained 12.5 l OneTaq Quick-load
2 master mix, 0.75 l of dimethyl sulfoxide ([DMSO] Sigma-Aldrich), 2.2 l of the primer mix, 2 l of
gDNA for each isolate (at 10 ng/l),and 7.55 l UltraPure H2O (Life Technologies) to a ﬁnal volume of
25 l. Ratios of the primers in the primer mix can be found in Table 3. Positive-control isolates were
chosen based on the presence of the target gene in their genome sequence. Negative-control isolates
were chosen based on the absence of the target gene in their genome sequence. A negative control of
UltraPure H2O was also used for each PCR performed in this study. Gel electrophoresis was performed
using 2.0% agarose gel with 5% SybrSafe dye (Invitrogen) and run at 110 V for 90 min using the
Quick-load 100 bp DNA ladder (New England BioLabs) for all mPCRs. All mPCR results were visualized
using the GelDoc imager (Bio-Rad). The accuracy of the results for these individual PCRs was compared
with the expected results from the genome sequences and BLAST matches for the primers.
Validation of the pathotyping mPCR. The mPCR was evaluated using gDNA of 143 isolates from the
original collection and gDNA of 84 isolates of the additional collection (gDNA concentration 10 ng/l).
The expected amplicon pattern for each isolate in the original collection was based on the presence/
absence of the 10 genes from their genome sequence (23). After the mPCR was performed, the amplicon
pattern was entered into the ﬁnal model and the ﬁtted model value was calculated. The accuracy,
sensitivity, and speciﬁcity of the mPCR results were calculated using the cutoff of 0.72 and the known
clinical category. For the additional isolate collection, the mPCR results were entered into the model, and
the output was compared with clinical metadata. All mPCRs were repeated on three occasions, each time
using a separate master mix, to demonstrate the repeatability and accuracy of the mPCR.
To determine whether the mPCR could detect H. parasuis directly from a single colony, thus not
requiring prior gDNA extraction, colony PCR was performed on a subset of the additional isolate
collection (n  20). For the colony PCR, a loopful of bacteria was resuspended in 50 l of UltraPure H2O
and heated at 100°C for 30 min, and then centrifuged at 4,000  g for 1 min before the supernatant was
used in the mPCR. The supernatant (2 l) was used in the mPCR reaction.
Limit of detection of the mPCR. The concentration of gDNA was measured using a Qubit
ﬂuorometer (Life Technologies) with broad-range standards for ﬁve isolates (strain name-serovar: HS145-
S1, SW140-S2, Nagasaki-S5, C5-S8, D74-Aus–S9, and IA84/17975-S13). The gDNA was diluted six times in
a serial dilution using UltraPure H2O; this was then used as the template in the mPCR to estimate its limit
of detection. The number of copies of the genome per microliter was calculated using an average
genome size of 2.26 Mb.
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